Updated results of the phase 1 I-FLOAT trial: Safety and efficacy of combining genotype-guided irinotecan with 5FU, leucovorin, oxaliplatin and docetaxel (gFOLFOXIRITAX) in advanced upper GI cancers.
| Autor: | Paydary, Koosha, Loew, Colton, Desgardin, Aurelie, Shergill, Ardaman, Reizine, Natalie Marie, Robinzine, Chanelle, Racette, Christine, Ignatiev, Elena, Neerukonda, Anu Radha, Ji, Yuan, Polite, Blase N., Liao, Chih-Yi |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe16038-e16038, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|